Cannabis Medical & Pharma

Kanabo Group is a London-headquartered medical cannabis company listed on the London Stock Exchange. The company develops and distributes medical cannabis products, including its proprietary vaporization technology and cannabis formulations. Following its acquisition of GPS (The GP Service), Kanabo expanded into medical cannabis clinic operations in the UK.

MGC Pharmaceuticals is a European pharmaceutical company listed on the London Stock Exchange, specializing in the production and development of cannabinoid-based medicines. The company operates manufacturing facilities in Malta and Slovenia, and is developing its flagship product CannEpil for drug-resistant epilepsy. MGC Pharma pursues a pharmaceutical-grade approach with clinical trials and regulatory approvals.

Sapphire Medical Clinics is the largest medical cannabis clinic network in the United Kingdom, providing specialist consultations and prescriptions for medical cannabis. The clinic operates the UK Medical Cannabis Registry, one of the world's largest observational studies on medical cannabis outcomes. Sapphire has treated thousands of patients across a wide range of conditions including chronic pain, anxiety, and PTSD.

The Medical Cannabis Clinics (TMCC) is a UK-based medical cannabis service that connects patients with specialist doctors who can prescribe cannabis-based medicines. TMCC offers consultations both online and in-person, providing access to a range of cannabis flower and oil products from licensed pharmacies. The clinic serves patients across England, Scotland, and Wales.

Zerenia Clinics is a UK medical cannabis clinic offering specialist consultations and prescriptions for patients who have not responded adequately to conventional treatments. The clinic provides a patient-focused approach with ongoing support and monitoring. Zerenia combines clinical expertise with a compassionate care model to help patients access legal medical cannabis in the UK.

Lyphe Group is Europe's largest medical cannabis platform, operating clinics, pharmacies, and technology infrastructure across the UK and Germany. The group's portfolio includes Mamedica clinics, LYPHE Dispensary pharmacy, and digital health tools for patient management. Lyphe Group has built an integrated ecosystem connecting patients, physicians, and cannabis product suppliers.

GW Pharmaceuticals, now part of Jazz Pharmaceuticals, is the world's leading cannabinoid pharmaceutical company and creator of Epidiolex, the first FDA-approved plant-derived cannabinoid medicine. Based in Cambridge, UK, GW pioneered the development of prescription cannabinoid medicines through rigorous clinical trials. The company's Epidiolex is approved for treating severe forms of epilepsy including Dravet and Lennox-Gastaut syndromes.

Integro Clinics is a specialist medical cannabis clinic offering consultations with experienced physicians. The clinic provides access to prescribed cannabis-based medicines for patients with qualifying conditions under the UK regulatory framework.

Cantourage UK is the British arm of the German-listed medical cannabis company, operating clinics and distributing a wide range of cannabis flower and oil products to UK patients through its pharmacy partnerships.

MyAccess Clinics provides affordable medical cannabis consultations and prescriptions for UK patients. The clinic focuses on accessibility with competitive pricing and streamlined online booking.

Little Green Pharma is an Australian medical cannabis company that cultivates, manufactures, and distributes cannabis products domestically and into Europe.

Althea Group is an Australian medical cannabis company supplying pharmaceutical-grade products to patients in Australia and the UK through its clinic and distribution network.

AusCann is an Australian pharmaceutical cannabis company developing cannabinoid medicines. It focuses on hard-shell capsule formulations with consistent dosing.

Cannatrek is a leading Australian medical cannabis supplier providing a wide range of flower and oil products to patients through the TGA Special Access Scheme.

Levin Health is an Australian medical cannabis clinic group connecting patients with prescribing doctors. It focuses on accessible, evidence-based cannabis medicine.

MGC Pharmaceuticals is an ASX-listed bio-pharma company developing cannabinoid-based medicines. It operates production facilities in Europe with R&D based in Australia.

Creso Pharma develops and commercializes cannabis and hemp-based therapeutic products for human and animal health, with operations spanning Australia, Canada, and Europe.

CannaPal Animal Therapeutics develops cannabinoid-based veterinary medicines, pioneering cannabis treatments for companion animals in Australia's regulated market.

Zelira Therapeutics is a clinical-stage pharmaceutical company developing evidence-based cannabinoid therapies for insomnia, chronic pain, and autism-related conditions.

Bod Australia manufactures and distributes medicinal cannabis products and CBD skincare, supplying the Australian, UK, and Southeast Asian markets through pharmacy and clinical channels.

Tikun Olam is Israel's pioneering medical cannabis company and one of the first licensed producers in the country. It operates large-scale cultivation and conducts extensive clinical research.

InterCure is Israel's largest medical cannabis company, operating the Canndoc brand. It is vertically integrated across cultivation, manufacturing, distribution, and pharmacy retail.

Together Pharma is an Israeli medical cannabis company engaged in cultivation, processing, and distribution. It also imports products from international partners.

Panaxia Labs is a pharmaceutical cannabis company specializing in advanced delivery systems including tablets, capsules, and inhalers. It operates GMP-certified labs in Israel.

PhytoTech Therapeutics is an Israeli pharmatech company developing novel cannabinoid drug delivery platforms. It focuses on oral and sublingual formulations.

Cannassure Therapeutics develops and manufactures pharmaceutical-grade cannabis products under GMP standards, specializing in sublingual tablets and novel delivery systems for the Israeli and export markets.

Tetra Bio-Pharma is an Ottawa-based biopharmaceutical company focused on developing cannabinoid-based prescription drug products. The company pursues the drug development pathway to bring cannabis-derived medicines through clinical trials and regulatory approval, bridging the gap between cannabis and traditional pharmaceuticals.

Cardiol Therapeutics is an Oakville, Ontario-based clinical-stage biopharmaceutical company focused on developing cannabidiol (CBD) based therapies for heart disease. The company is pursuing a novel approach to treating cardiovascular inflammation using pharmaceutical-grade CBD formulations.

InMed Pharmaceuticals is a Vancouver-based pharmaceutical company developing cannabinoid-based therapies and manufacturing technologies for rare cannabinoids. The company combines drug development with proprietary biosynthesis technology for producing pharmaceutical-grade cannabinoids at scale.

Entourage Health Corp, formerly WeedMD, is an Oshawa, Ontario-based cannabis company focused on the medical cannabis market. The company operates cultivation facilities in Ontario and serves both the Canadian medical cannabis patient market and select international medical markets.

Kalytera Therapeutics is a biopharmaceutical company focused on developing cannabinoid-based therapeutics for various medical conditions. The company conducts research and development of pharmaceutical products derived from cannabinoids for therapeutic applications.

Cannabix Technologies is a Canadian technology company based in Vancouver, British Columbia that develops breath testing devices and technologies for detecting recent cannabis use. The company focuses on creating solutions for law enforcement, workplaces, and other organizations to identify THC impairment through breath analysis.

Ease Labs is a Brazilian medical cannabis company authorized by ANVISA to produce and distribute cannabis-based medicines. It focuses on pharmaceutical-grade products for patients.

Verdemed is a Brazilian cannabis company importing and distributing medical cannabis products under ANVISA regulations to patients across Brazil.

Prati-Donaduzzi is a major Brazilian pharmaceutical company that produced Brazil's first domestically manufactured cannabis-based medicine, marking a milestone in the country's medical cannabis history.

Nunature is a Brazilian cannabis health company developing and importing medical cannabis products for the Brazilian market under ANVISA regulatory pathways.

Dr Cannabis BR is a Brazilian healthtech platform connecting patients with cannabis-prescribing physicians and facilitating access to medical cannabis products through telemedicine.

Prati-Donaduzzi Cannabis is the cannabis division of major Brazilian pharmaceutical company Prati-Donaduzzi, producing the country's first domestically manufactured cannabis-based medicine.

Sanity Group is a Berlin-based cannabis health company that operates multiple brands across medical and consumer wellness segments. Its medical arm Vayamed distributes pharmaceutical cannabis to pharmacies, while avaay focuses on CBD wellness products. Backed by significant venture capital including investment from Casa Verde Capital, Sanity Group is one of Europe's most well-funded cannabis startups.

Nimbus Health is a Leipzig-based medical cannabis company focused on importing and distributing pharmaceutical-grade cannabis products in Germany. The company emphasizes scientific research and evidence-based approaches to medical cannabis, working closely with physicians and pharmacists. Nimbus Health provides a curated selection of EU-GMP-certified cannabis flowers and extracts to the German pharmacy market.

Algea Care is Germany's leading telemedicine platform for medical cannabis, connecting patients with specialized physicians for online consultations and prescriptions. The platform has streamlined the patient journey from initial consultation to prescription fulfillment, making medical cannabis more accessible across Germany. Algea Care has facilitated tens of thousands of patient consultations since launch.

Enua is a Berlin-based digital health platform focused on simplifying access to medical cannabis in Germany. The company offers an integrated platform combining telemedicine consultations, digital prescriptions, and home delivery of medical cannabis products. Enua aims to remove barriers in the patient journey by providing an end-to-end digital experience.

The ACM is Germany's leading medical cannabis research and advocacy organization, founded by Dr. Franjo Grotenhermen, promoting scientific research on therapeutic cannabis use.

Specialized cannabis-dispensing pharmacy in Frankfurt am Main providing EU-GMP medical cannabis products with comprehensive patient counseling.

EMMAC Life Sciences, now operating as Curaleaf International following its acquisition by Curaleaf Holdings, is one of Europe's largest independent medical cannabis companies. With operations spanning the UK, Germany, Italy, and Portugal, the company has built a pan-European platform covering cultivation, processing, and distribution. The Rome office oversees Southern European operations and Italian market development.

Curaleaf International (formerly EMMAC Life Sciences) is the European arm of Curaleaf Holdings. It distributes medical cannabis across Europe with key operations in Italy, Germany, and the UK.

Italian subsidiary of Canadian LP Tilray, supplying GMP-grade medical cannabis products to Italian pharmacies through the national health system.

Italian arm of Aurora Cannabis supplying pharmaceutical-grade medical cannabis to the Italian market through authorised distribution channels.

Italian distribution arm of Dutch pharmaceutical cannabis producer Bedrocan, supplying standardised medical cannabis to the Italian healthcare system.

Apulian pharmaceutical company authorised to import, process, and distribute medical cannabis raw materials to Italian compounding pharmacies.

Trulieve GA operates as part of Trulieve Cannabis Corp's expansion into Georgia's limited medical cannabis market, providing low-THC oil products to registered patients.

Botanical Sciences GA is one of Georgia's licensed medical cannabis producers, cultivating and processing low-THC cannabis oil for registered patients under the Hope Act.

FFD Georgia is a licensed medical cannabis company producing and distributing low-THC oil products under Georgia's Hope Act framework for qualifying patients.

Capital City Care is one of Washington DC's original medical cannabis dispensaries, providing registered patients with locally cultivated flower and a comprehensive product menu.

Herbal Alternatives is a DC medical dispensary offering a curated selection of cannabis flower, edibles, and concentrates to registered patients in the nation's capital.

National Holistic Healing Center is a vertically integrated DC medical cannabis dispensary and cultivator offering patients a wide variety of in-house grown strains.

Helius Therapeutics is New Zealand's leading medical cannabis company, operating a licensed cultivation and GMP manufacturing facility in Auckland.

Rua Bioscience is an NZX-listed medical cannabis company based in Gisborne. It has Maori ownership and focuses on bringing affordable medical cannabis to New Zealanders.

Helius Clinics is the patient-facing division of Helius Therapeutics, providing specialist medical cannabis consultations and treatment plans across New Zealand.

Rua Bioscience Retail is the patient access arm of NZX-listed Rua Bioscience, connecting patients in the Gisborne region with locally produced medical cannabis.